טוען...
Low prevalence and disease severity of COVID‐19 in post‐liver transplant recipients—A single centre experience
Coronavirus disease 2019 (COVID‐19) caused by a novel coronavirus called severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) is driving a present day global pandemic. Immunosuppressed patients are regarded as a high‐risk cohort. The following is a short report on COVID‐19 in liver transplan...
שמור ב:
| הוצא לאור ב: | Liver Int |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7300707/ https://ncbi.nlm.nih.gov/pubmed/32471013 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.14552 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|